BRAINSTORM CELL THERAPEUTICS INC. Operating Lease, Payments
BRAINSTORM CELL THERAPEUTICS INC. (BCLI) reported Operating Lease, Payments of $279.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:OperatingLeasePayments · last filed 2026-08-14
- BRAINSTORM CELL THERAPEUTICS INC. operating lease, payments for the quarter ending 2026-06-30 was $80.00K, a 53.22% decline year-over-year.
- BRAINSTORM CELL THERAPEUTICS INC. operating lease, payments for the quarter ending 2026-03-31 was $199.00K, a 16.37% increase year-over-year.
- BRAINSTORM CELL THERAPEUTICS INC. operating lease, payments for the quarter ending 2025-12-31 was $190.00K, a 14.46% increase year-over-year.
- BRAINSTORM CELL THERAPEUTICS INC. operating lease, payments for the quarter ending 2025-09-30 was $180.00K, a 9.09% increase year-over-year.
- BRAINSTORM CELL THERAPEUTICS INC. operating lease, payments for fiscal 2025 was $712.00K, a 7.55% increase from fiscal 2024.
- BRAINSTORM CELL THERAPEUTICS INC. operating lease, payments for fiscal 2024 was $662.00K, a 49.58% decline from fiscal 2023.
- BRAINSTORM CELL THERAPEUTICS INC. operating lease, payments for fiscal 2023 was $1.31M, a 14.63% decline from fiscal 2022.
- BRAINSTORM CELL THERAPEUTICS INC. operating lease, payments for fiscal 2022 was $1.54M, a 44.42% decline from fiscal 2021.
| Period end | Operating Lease, Payments 3 month | Operating Lease, Payments 3 month as first filed | Operating Lease, Payments 6 month | Operating Lease, Payments 6 month as first filed | Operating Lease, Payments 9 month | Operating Lease, Payments 9 month as first filed | Operating Lease, Payments 12 month | Operating Lease, Payments 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $80.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $279.00K 10-Q · filed 2026-08-14 | $469.00K derived: sum of 3 quarters · filed 2026-08-14 | $649.00K derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2026-03-31 | $199.00K 10-Q · filed 2026-05-15 | $389.00K derived: sum of 2 quarters · filed 2026-05-15 | $569.00K derived: sum of 3 quarters · filed 2026-05-15 | $740.00K derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-12-31 | $190.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $370.00K derived: sum of 2 quarters · filed 2026-03-31 | $541.00K derived: sum of 3 quarters · filed 2026-08-14 | $712.00K 10-K · filed 2026-03-31 | ||||
| 2025-09-30 | $180.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $351.00K derived: sum of 2 quarters · filed 2026-08-14 | $522.00K 10-Q · filed 2025-11-14 | $688.00K derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-06-30 | $171.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $342.00K 10-Q · filed 2026-08-14 | $508.00K derived: sum of 3 quarters · filed 2026-08-14 | $673.00K derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-03-31 | $171.00K 10-Q · filed 2026-05-15 | $337.00K derived: sum of 2 quarters · filed 2026-05-15 | $502.00K derived: sum of 3 quarters · filed 2026-05-15 | $667.00K derived: sum of 4 quarters · filed 2026-05-15 | ||||
| 2024-12-31 | $166.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $331.00K derived: sum of 2 quarters · filed 2026-03-31 | $496.00K derived: sum of 3 quarters · filed 2026-03-31 | $662.00K 10-K · filed 2026-03-31 | ||||
| 2024-09-30 | $165.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $330.00K derived: sum of 2 quarters · filed 2025-11-14 | $496.00K 10-Q · filed 2025-11-14 | $709.00K derived: sum of 4 quarters · filed 2025-11-14 | ||||
| 2024-06-30 | $165.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $331.00K 10-Q · filed 2025-08-14 | $544.00K derived: sum of 3 quarters · filed 2025-08-14 | $900.00K derived: sum of 4 quarters · filed 2025-08-14 | ||||
| 2024-03-31 | $166.00K 10-Q · filed 2025-05-15 | $379.00K derived: sum of 2 quarters · filed 2025-05-15 | $735.00K derived: sum of 3 quarters · filed 2025-05-15 | $1.09M derived: sum of 4 quarters · filed 2025-05-15 | ||||
| 2023-12-31 | $213.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $569.00K derived: sum of 2 quarters · filed 2025-03-31 | $927.00K derived: sum of 3 quarters · filed 2025-03-31 | $1.31M 10-K · filed 2025-03-31 | ||||
| 2023-09-30 | $356.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $714.00K derived: sum of 2 quarters · filed 2024-11-14 | $1.10M 10-Q · filed 2024-11-14 | $1.91M 10-Q · filed 2023-11-14 | $593.00K derived: sum of 4 quarters · filed 2024-11-14 | |||
| 2023-06-30 | $358.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $744.00K 10-Q · filed 2024-08-14 | $1.29M 10-Q · filed 2023-08-14 | $237.00K derived: sum of 3 quarters · filed 2024-08-14 | $914.00K derived: sum of 4 quarters · filed 2024-08-14 | |||
| 2023-03-31 | $386.00K 10-Q · filed 2024-05-14 | $657.00K 10-Q · filed 2023-05-15 | -$121.00K derived: sum of 2 quarters · filed 2024-05-14 | $556.00K derived: sum of 3 quarters · filed 2024-05-14 | $1.25M derived: sum of 4 quarters · filed 2024-05-14 | |||
| 2022-12-31 | -$507.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $170.00K derived: sum of 2 quarters · filed 2024-04-01 | $861.00K derived: sum of 3 quarters · filed 2024-04-01 | $1.54M 10-K · filed 2024-04-01 | $2.71M 10-K · filed 2023-03-30 | |||
| 2022-09-30 | $677.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $1.37M derived: sum of 2 quarters · filed 2022-11-14 | $2.04M 10-Q · filed 2022-11-14 | $2.75M derived: sum of 4 quarters · filed 2022-11-14 | ||||
| 2022-06-30 | $691.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $1.37M 10-Q · filed 2022-08-15 | $2.08M derived: sum of 3 quarters · filed 2022-08-15 | $2.77M derived: sum of 4 quarters · filed 2022-08-15 | ||||
| 2022-03-31 | $677.00K 10-Q · filed 2022-05-16 | $1.39M derived: sum of 2 quarters · filed 2022-05-16 | $2.08M derived: sum of 3 quarters · filed 2022-05-16 | $2.76M derived: sum of 4 quarters · filed 2022-05-16 | ||||
| 2021-12-31 | $709.00K derived: 10-K 12 month − 3 quarters · filed 2022-03-28 | $1.40M derived: sum of 2 quarters · filed 2022-03-28 | $2.08M derived: sum of 3 quarters · filed 2022-03-28 | $2.77M 10-K · filed 2022-03-28 | ||||
| 2021-09-30 | $690.00K 10-Q · filed 2021-11-15 | $1.37M derived: sum of 2 quarters · filed 2021-11-15 | $2.06M derived: sum of 3 quarters · filed 2021-11-15 | $2.50M derived: sum of 4 quarters · filed 2021-11-15 | ||||
| 2021-06-30 | $684.00K 10-Q · filed 2021-08-05 | $1.37M derived: sum of 2 quarters · filed 2021-08-05 | $1.81M derived: sum of 3 quarters · filed 2021-08-05 | $2.14M derived: sum of 4 quarters · filed 2021-08-05 | ||||
| 2021-03-31 | $684.00K 10-Q · filed 2021-04-26 | $1.13M derived: sum of 2 quarters · filed 2021-04-26 | $1.45M derived: sum of 3 quarters · filed 2021-04-26 | $1.78M derived: sum of 4 quarters · filed 2021-04-26 | ||||
| 2020-12-31 | $444.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-04 | $770.00K derived: sum of 2 quarters · filed 2021-02-04 | $1.10M derived: sum of 3 quarters · filed 2021-02-04 | $1.42M 10-K · filed 2021-02-04 | ||||
| 2020-09-30 | $326.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-15 | $652.00K derived: sum of 2 quarters · filed 2020-10-15 | $979.00K 10-Q · filed 2020-10-15 | $1.31M derived: sum of 4 quarters · filed 2020-10-15 | ||||
| 2020-06-30 | $326.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | $653.00K 10-Q · filed 2020-08-05 | $984.00K derived: sum of 3 quarters · filed 2020-08-05 | $1.31M derived: sum of 4 quarters · filed 2020-08-05 | ||||
| 2020-03-31 | $327.00K 10-Q · filed 2020-05-07 | $658.00K derived: sum of 2 quarters · filed 2020-05-07 | $985.00K derived: sum of 3 quarters · filed 2020-05-07 | $1.31M derived: sum of 4 quarters · filed 2020-05-07 | ||||
| 2019-12-31 | $331.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-18 | $658.00K derived: sum of 2 quarters · filed 2020-02-18 | $979.00K derived: sum of 3 quarters · filed 2020-02-18 | $1.30M 10-K · filed 2020-02-18 | ||||
| 2019-09-30 | $327.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | $648.00K derived: sum of 2 quarters · filed 2019-11-14 | $965.00K 10-Q · filed 2019-11-14 | |||||
| 2019-06-30 | $321.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-13 | $638.00K 10-Q · filed 2019-08-13 | ||||||
| 2019-03-31 | $317.00K 10-Q · filed 2019-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| Pluri Inc. (PLUR) | $0.014B | ||
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |